EPISODE · Jul 10, 2012 · 28 MIN
Barriers to Prescribing Crizotinib Following FDA Approval
from JCO Oncology Practice Podcast
by Robert S. Miller, MD. Dr. Nathan Pennell discusses some of the interesting obstacles he encountered when trying to prescribe crizotinib for 3 patients with ALK positive non-small cell lung cancer in the first few weeks following FDA approval in 2011.
Embed this episode
NOW PLAYING
Barriers to Prescribing Crizotinib Following FDA Approval
0:00
28:32
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JCO Oncology Practice Podcast?
This episode is 28 minutes long.
When was this JCO Oncology Practice Podcast episode published?
This episode was published on July 10, 2012.
Can I download this JCO Oncology Practice Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!